Cyclosporine A reduces microvascular obstruction and preserves left ventricular function deterioration following myocardial ischemia and reperfusion

Basic Research in Cardiology

Volumn 110, Issue 2, 2015, Pages 1-17

  Zalewski, Jaroslaw ^a,b   Claus, Piet ^a   Bogaert, Jan ^c   Driessche, Nina Vanden ^a   Driesen, Ronald B ^a   Galan, Diogo T ^a   Sipido, Karin R ^a   Buszman, Piotr ^d   Milewski, Krzysztof ^d   Van de Werf, Frans ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b JAGIELLONIAN UNIVERSITY   (Poland)

^c DEPARTMENT OF IMAGING AND PATHOLOGY   (Belgium)

^d Center for Cardiovascular Research and Development American Heart of Poland   (Poland)

Author keywords

Cardiovascular magnetic resonance imaging; Cyclosporine A; Microvascular obstruction; Myocardial infarction; Postconditioning

Indexed keywords

CYCLOSPORIN A; EVANS BLUE; GADOLINIUM; TRIPHENYLTETRAZOLIUM; CYCLOSPORIN; ENZYME INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BALLOON DILATATION; BLOOD VESSEL OCCLUSION; CARDIOVASCULAR MAGNETIC RESONANCE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE BLOOD FLOW; HISTOPATHOLOGY; ISCHEMIC POSTCONDITIONING; MALE; MICROVASCULAR OBSTRUCTION; NONHUMAN; PREDICTION; REPERFUSION INJURY; SWINE; ANIMAL; DISEASE MODEL; HEART INFARCTION; MYOCARDIAL REPERFUSION INJURY; PATHOLOGY; PATHOPHYSIOLOGY; PIG; PROCEDURES;

ANIMALS; CYCLOSPORINE; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; FEMALE; ISCHEMIC POSTCONDITIONING; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; SWINE;

EID: 84923767915     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-015-0475-8     Document Type: Article

References (57)

1. 2+-induced mitochondrial permeability transition. Cardiovasc Res 61:115–122. doi:10.1016/j.cardiores.2003.11.003
2. Baines CP (2009) The mitochondrial permeability transition pore and ischemia-reperfusion injury. Basic Res Cardiol 104:181–188. doi:10.1007/s00395-009-0004-8
3. Baines CP, Kaiser RA, Purcell NH, Blair NS, Osinska H, Hambleton MA, Brunskill EW, Sayen MR, Gottlieb RA, Dorn GW, Robbins J, Molkentin JD (2005) Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434:658–662. doi:10.1038/nature03434
4. Bergerot C, Mewton N, Lacote-Roiron C, Ernande L, Ovize M, Croisille P, Thibault H, Derumeaux G (2014) Influence of microvascular obstruction on regional myocardial deformation in the acute phase of myocardial infarction: a speckle-tracking echocardiography study. J Am Soc Echocardiogr 27:93–100. doi:10.1016/j.echo.2013.09.011
5. Bogaert J, Kalantzi M, Rademakers FE, Dymarkowski S, Janssens S (2007) Determinants and impact of microvascular obstruction in successfully reperfused ST-segment elevation myocardial infarction. Assessment by magnetic resonance imaging. Eur Radiol 17:2572–2580. doi:10.1007/s00330-007-0627-9
6. Braunwald E, Kloner RA (1985) Myocardial reperfusion: a double-edged sword? J Clin Invest 76:1713–1719. doi:10.1172/JCI112160
7. Christian TF, Rettmann DW, Aletras AH, Liao SL, Taylor JL, Balaban RS, Arai AE (2004) Absolute myocardial perfusion in canines measured by using dual-bolus first-pass MR imaging. Radiology 232:677–684. doi:10.1148/radiol.2323030573
8. Cohen MV, Yang XM, Downey JM (2007) The pH hypothesis of postconditioning: staccato reperfusion reintroduces oxygen and perpetuates myocardial acidosis. Circulation 115:1895–1903. doi:10.1161/CIRCULATIONAHA.106.675710
9. Di Lisa F, Menabo R, Canton M, Barile M, Bernardi P (2001) Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD(+) and is a causative event in the death of myocytes in postischemic reperfusion of the heart. J Biol Chem 276:2571–2575. doi:10.1074/jbc.M006825200
10. Diaz RJ, Fernandes K, Lytvyn Y, Hawrylyshyn K, Harvey K, Hossain T, Hinek A, Wilson GJ (2013) Enhanced cell-volume regulation in cyclosporin A cardioprotection. Cardiovasc Res 98:411–419
11. doi:10.1093/cvr/cvt056
12. Dow J, Kloner RA (2007) Postconditioning does not reduce myocardial infarct size in an in vivo regional ischemia rodent model. J Cardiovasc Pharmacol Ther 12:153–163. doi:10.1177/1074248407300897
13. Ezekowitz JA, Armstrong PW, Granger CB, Theroux P, Stebbins A, Kim RJ, Patel MR (2010) Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: an assessment of pexelizumab in acute myocardial infarction (APEX-AMI) substudy. Am Heart J 160:272–278. doi:10.1016/j.ahj.2010.05.035
14. Fishbein MC, Y-Rit J, Lando U, Kanmatsuse K, Mercier JC, Ganz W (1980) The relationship of vascular injury and myocardial hemorrhage to necrosis after reperfusion. Circulation 62:1274–1279. doi:10.1161/01.CIR.62.6.1274
15. Freixa X, Bellera N, Ortiz-Pérez JT, Jiménez M, Paré C, Bosch X, De Caralt TM, Betriu A, Masotti M (2012) Ischaemic postconditioning revisited: lack of effects on infarct size following primary percutaneous coronary intervention. Eur Heart J 33:103–112. doi:10.1093/eurheartj/ehr297
16. Gateau-Roesch O, Argaud L, Ovize M (2006) Mitochondrial permeability transition pore and postconditioning. Cardiovasc Res 70:264–273. doi:10.1016/j.cardiores.2006.02.024
17. Gedik N, Heusch G, Skyschally A (2013) Infarct size reduction by cyclosporine A at reperfusion involves inhibition of the mitochondrial permeability transition pore but does not improve mitochondrial respiration. Arch Med Sci 6:968–975. doi:10.5114/aoms.2013.38175
18. Griffiths EJ, Halestrap AP (1993) Protection by cyclosporin A of ischemia/reperfusion-induced damage in isolated rat hearts. J Mol Cell Cardiol 25:1461–1469. doi:10.1006/jmcc.1993.1162
19. Hahn JY, Song YB, Kim EK, Yu CW, Bae JW, Chung WY, Choi SH, Choi JH, Bae JH, An KJ, Park JS, Oh JH, Kim SW, Hwang JY, Ryu JK, Park HS, Lim DS, Gwon HC (2013) Ischemic postconditioning during primary percutaneous coronary intervention: the effects of postconditioning on myocardial reperfusion in patients with ST-segment elevation myocardial infarction (POST) randomized trial. Circulation 128:1889–1896. doi:10.1161/CIRCULATIONAHA.113.001690
20. Hale SL, Mehra A, Leeka J, Kloner RA (2008) Postconditioning fails to improve no reflow or alter infarct size in an open-chest rabbit model of myocardial ischemia-reperfusion. Am J Physiol Heart Circ Physiol 294:H421–H425. doi:10.1152/ajpheart.00962.2007
21. Hausenloy DJ, Kunst G, Boston-Griffiths E, Kolvekar S, Chaubey S, John L, Desai J, Yellon D (2014) The effect of cyclosporin-A on peri-operative myocardial injury in adult patients undergoing coronary artery bypass graft surgery: a randomised controlled clinical trial. Heart 100:544–549. doi:10.1136/heartjnl-2013-304845
22. Hausenloy DJ, Tsang A, Yellon DM (2005) The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning. Trends Cardiovasc Med 15:69–75. doi:10.1016/j.tcm.2005.03.001
23. Hearse DJ, Bolli R (1992) Reperfusion induced injury: manifestations, mechanisms, and clinical relevance. Cardiovasc Res 26:101–108. doi:10.1093/cvr/26.2.101
24. Heusch G, Kleinbongard P, Skyschally A (2013) Myocardial infarction and coronary microvascular obstruction: an intimate, but complicated relationship. Basic Res Cardiol 108:380. doi:10.1007/s00395-013-0380-y
25. Heusch G, Libby P, Gersh B, Yellon D, Böhm M, Lopaschuk G, Opie L (2014) Cardiovascular remodelling in coronary artery disease and heart failure. Lancet 383:1933–1943. doi:10.1016/S0140-6736(14)60107-0
26. Heusch G, Musioloik G, Gedik N, Skyschally A (2011) Mitochondrial STAT3 activation and cardioprotection by ischemic postconditioning in pigs with regional myocardial ischemia/reperfusion. Circ Res 109:1302–1308. doi:10.1161/CIRCRESAHA.111.255604
27. Hsu LY, Rhoads KL, Holly JE, Kellman P, Aletras AH, Arai AE (2006) Quantitative myocardial perfusion analysis with a dual-bolus contrast-enhanced first-pass MRI technique in humans. J Magn Reson Imaging 23:315–322. doi:10.1002/jmri.20502
28. Iliodromitis EK, Georgiadis M, Cohen MV, Downey JM, Bofilis E, Kremastinos DT (2006) Protection from postconditioning depends on the number of short ischemic insults in anesthetized pigs. Basic Res Cardiol 101:502–507. doi:10.1007/s00395-006-0606-3
29. Jeremy RW, Links JM, Becker LC (1990) Progressive failure of coronary flow during reperfusion of myocardial infarction: documentation of the no reflow phenomenon with positron emission tomography. J Am Coll Cardiol 16:695–704. doi:10.1016/0735-1097(90)90362-S
30. Karlsson LO, Bergh N, Grip L (2012) Cyclosporine A, 2.5 mg/kg, does not reduce myocardial infarct size in a porcine model of ischemia and reperfusion. J Cardiovasc Pharmacol Ther 17:159–163. doi:10.1177/1074248411407636
31. Karlsson LO, Zhou AX, Larsson E, Aström-Olsson K, Månsson C, Akyürek LM, Grip L (2010) Cyclosporine does not reduce myocardial infarct size in a porcine ischemia-reperfusion model. J Cardiovasc Pharmacol Ther 15:182–189. doi:10.1177/1074248410362074
32. Kloner RA (2013) Current state of clinical translation of cardioprotective agents for acute myocardial infarction. Circ Res 113:451–463. doi:10.1161/CIRCRESAHA.112.300627
33. Kloner RA, Ganote CE, Jennings RB (1974) The “no-reflow” phenomenon after temporary coronary occlusion in the dog. J Clin Invest 54:1496–1508. doi:10.1172/JCI107898
34. Kloner RA, Rude RE, Carlson N, Maroko PR, DeBoer LW, Braunwald E (1980) Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: which comes first? Circulation 62:945–952. doi:10.1161/01.CIR.62.5.945
35. Lie RH, Stoettrup N, Sloth E, Hasenkam JM, Kroyer R, Nielsen TT (2010) Post-conditioning with cyclosporine A fails to reduce the infarct size in an in vivo porcine model. Acta Anaesthesiol Scand 54:804–813. doi:10.1111/j.1399-6576.2010.02241.x
36. Lim WY, Messow CM, Berty C (2012) Cyclosporin variably and inconsistently reduces infarct size in experimental models of reperfused myocardial infarction: a systematic review and meta-analysis. British J Pharmacol 165:2034–2043. doi:10.1111/j.1476-5381.2011.01691.x
37. Liu X, Huang X, Pokreisz P, Vermeersch P, Marsboom G, Swinnen M, Verbeken E, Santos J, Pellens M, Gillijns H, Van de Werf F, Bloch KD, Janssens S (2007) Nitric oxide inhalation improves microvascular flow and decreases infarction size after myocardial ischemia and reperfusion. J Am Coll Cardiol 50:808–817. doi:10.1016/j.jacc.2007.04.069
38. Massoudy P, Zahler S, Kupatt C, Reder E, Becker BF, Gerlach E (1997) Cardioprotection by cyclosporine A in experimental ischemia and reperfusion—evidence for a nitric oxide-dependent mechanism mediated by endothelin. J Mol Cell Cardiol 29:535–544. doi:10.1006/jmcc.1996.0297
39. Mewton N, Thibault H, Roubille F, Lairez O, Rioufol G, Sportouch C, Sanchez I, Bergerot C, Cung TT, Finet G, Angoulvant D, Revel D, Bonnefoy-Cudraz E, Elbaz M, Piot C, Sahraoui I, Croisille P, Ovize M (2013) Postconditioning attenuates no-reflow in STEMI patients. Basic Res Cardiol 108:383. doi:10.1007/s00395-013-0383-8
40. Nakagawa T, Shimizu S, Watanabe T, Yamaguchi O, Otsu K, Yamagata H, Inohara H, Kubo T, Tsujimoto Y (2005) Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 434:652–658. doi:10.1038/nature03317
41. Nijveldt R, Beek AM, Hirsch A, Stoel MG, Hofman MB, Umans VA, Algra PR, Twisk JW, van Rossum AC (2008) Functional recovery after acute myocardial infarction: comparison between angiography, electrocardiography, and cardiovascular magnetic resonance measures of microvascular injury. J Am Coll Cardiol 52:181–189. doi:10.1016/j.jacc.2008.04.006
42. Okorie MI, Bhavsar DD, Ridout D, Charakida M, Deanfield JE, Loukogeorgakis SP, MacAllister RJ (2011) Postconditioning protects against human endothelial ischaemia-reperfusion injury via subtype-specific KATP channel activation and is mimicked by inhibition of the mitochondrial permeability transition pore. Eur Heart J 32:1266–1274. doi:10.1093/eurheartj/ehr041
43. Ørn S, Manhenke C, Greve OJ, Larsen AI, Bonarjee VV, Edvardsen T, Dickstein K (2009) Microvascular obstruction is a major determinant of infarct healing and subsequent left ventricular remodelling following primary percutaneous coronary intervention. Eur Heart J 30:1978–1985. doi:10.1093/eurheartj/ehp219
44. Piot C, Croisille P, Staat P, Thibault H, Rioufol G, Mewton N, Elbelghiti R, Cung TT, Bonnefoy E, Angoulvant D, Macia C, Raczka F, Sportouch C, Gahide G, Finet G, André-Fouët X, Revel D, Kirkorian G, Monassier JP, Derumeaux G, Ovize M (2008) Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med 359:473–481. doi:10.1056/NEJMoa071142
45. Reffelmann T, Hale SL, Li G, Kloner RA (2002) Relationship between no reflow and infarct size as influenced by the duration of ischemia and reperfusion. Am J Physiol 82:H766–H772. doi:10.1152/ajpheart.00767.2001
46. Reffelmann T, Kloner RA (2002) Microvascular reperfusion injury: rapid expansion of anatomic no reflow during reperfusion in the rabbit. Am J Physiol 283:H1099–H1107. doi:10.1152/ajpheart.00270.2002
47. Robbers LF, Eerenberg ES, Teunissen PF, Jansen MF, Hollander MR, Horrevoets AJ, Knaapen P, Nijveldt R, Heymans MW, Levi MM, van Rossum AC, Niessen HW, Marcu CB, Beek AM, van Royen N (2013) Magnetic resonance imaging-defined areas of microvascular obstruction after acute myocardial infarction represent microvascular destruction and haemorrhage. Eur Heart J 34:2346–2353. doi:10.1093/eurheartj/eht100
48. Schwartz LM, Lagranha CJ (2006) Ischemic postconditioning during reperfusion activates Akt and ERK without protecting against lethal myocardial ischemia-reperfusion injury in pigs. Am J Physiol 290:H1011–H1018. doi:10.1152/ajpheart.00864.2005
49. Skyschally A, Schulz R, Heusch G (2010) Cyclosporine A at reperfusion reduces infarct size in pigs. Cardiovasc Drugs Ther 24:85–87. doi:10.1007/s10557-010-6219-y
50. Skyschally A, Walter B, Heusch G (2013) Coronary microembolization during early reperfusion: infarct extension, but protection by ischaemic postconditioning. Eur Heart J 34:3314–3321. doi:10.1093/eurheartj/ehs434
51. Sorensson P, Saleh N, Bouvier F, Böhm F, Settergren M, Caidahl K, Tornvall P, Arheden H, Rydén L, Pernow J (2010) Effect of postconditioning on infarct size in patients with ST elevation myocardial infarction. Heart 96:1710–1715. doi:10.1136/hrt.2010.199430
52. Thuny F, Lairez O, Roubille F, Mewton N, Rioufol G, Sportouch C, Sanchez I, Bergerot C, Thibault H, Cung TT, Finet G, Argaud L, Revel D, Derumeaux G, Bonnefoy-Cudraz E, Elbaz M, Piot C, Ovize M, Croisille P (2012) Post-conditioning reduces infarct size and edema in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 59:2175–2181. doi:10.1016/j.jacc.2012.03.026
53. Wong DT, Leung MC, Richardson JD, Puri R, Bertaso AG, Williams K, Meredith IT, Teo KS, Worthley MI, Worthley SG (2012) Cardiac magnetic resonance derived late microvascular obstruction assessment post ST-segment elevation myocardial infarction is the best predictor of left ventricular function: a comparison of angiographic and cardiac magnetic resonance derived measurements. Int J Cardiovasc Imaging 28:1971–1981. doi:10.1007/s10554-012-0021-9
54. Wu KC, Zerhouni EA, Judd RM, Lugo-Olivieri CH, Barouch LA, Schulman SP, Blumenthal RS, Lima JA (1998) Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 97:765–772. doi:10.1161/01.CIR.97.8.765
55. Wu M, D’hooge J, Ganame J, Ferferieva V, Sipido KR, Maes F, Dymarkowski S, Bogaert J, Rademakers FE, Claus P (2011) Non-invasive characterization of the area-at-risk using magnetic resonance imaging in chronic ischaemia. Cardiovasc Res 89:166–174. doi:10.1093/cvr/cvq257
56. Yetgin T, Magro M, Manintveld OC, Nauta ST, Cheng JM, den Uil CA, Simsek C, Hersbach F, van Domburg RT, Boersma E, Serruys PW, Duncker DJ, van Geuns RJ, Zijlstra F (2014) Impact of multiple balloon inflations during primary percutaneous coronary intervention on infarct size and long-term clinical outcomes in ST-segment elevation myocardial infarction: real-world postconditioning. Basic Res Cardiol 109:403. doi:10.1007/s00395-014-0403-3
57. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, Vinten-Johansen J (2003) Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol 285:H579–H588. doi:10.1152/ajpheart.01064.2002